Evidence map›Paper›PMID 33885997›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2021

Non-aortic cardiovascular disease in Marfan syndrome: a nationwide epidemiological study.

Niels H Andersen, Kristian A Groth, Agnethe Berglund, Hanne Hove, Claus H Gravholt, Kirstine Stochholm

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. TGFβ-2 haploinsufficiency causes early death in mice with Marfan syndrome.Matrix biology : journal of the International Society for Matrix Biology · 2023
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Niels H AndersenDepartment of Cardiology, Aalborg University Hospital, Hobrovej 18-22, 9000, Aalborg, Denmark. dr.holmark@gmail.com.ORCID http://orcid.org/0000-0002-5394-3016
Kristian A GrothDepartment of Cardiology, Aalborg University Hospital, Hobrovej 18-22, 9000, Aalborg, Denmark.
Agnethe BerglundDepartment of Clinical Genetics, Aarhus University Hospital, Palle Juul-Jensens Boulevard, 8200, Aarhus, Denmark.ORCID http://orcid.org/0000-0001-9185-1342
Hanne HoveCenter for Rare Diseases, Department of Pediatrics, Copenhagen University Hospital, Rigshospitalet, 2100, Copenhagen , Denmark.
Claus H GravholtDepartment of Endocrinology, Aarhus University Hospital, Palle Juul-Jensens Boulevard, 8200, Aarhus, Denmark.ORCID http://orcid.org/0000-0001-5924-1720
Kirstine StochholmDepartment of Endocrinology, Aarhus University Hospital, Palle Juul-Jensens Boulevard, 8200, Aarhus, Denmark.ORCID http://orcid.org/0000-0002-4408-3413
Aarhus University Hospital · DKAalborg University Hospital · DKCopenhagen University Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesStudies indicate that other cardiovascular problems than aortic disease are a burden for patients with Marfan syndrome (MFS). The aim of the study was to assess the extent of this issue.

methodsA registry-based population study of patients with a Ghent II verified MFS diagnosis. Each patient was matched with up to 100 controls on age and sex. From the Danish healthcare system, we identified 407 MFS patients (from 1977 to 2014) and their cardiovascular events and compared them with those in 40,700 controls. Total follow-up time was 16,439 person years.

resultsMitral valve disease was significantly more common in MFS [HR: 58.9 (CI 38.1-91.1)] and happened earlier and more often in women than men with MFS [age at first registration: 22 vs. 38 years, HR: 2.1 (CI 1.0-4.4)]. Heart failure/cardiomyopathy was also more common in MFS [HR: 8.7 (CI 5.7-13.4)] and men were more affected than women, and at younger age [39 vs. 64 years, HR: 0.18 (CI 0.06-0.55)]. In all cases, atrioventricular block [HR: 4.9 (1.5-15.6)] was related to heart surgery. Supraventricular [HR: 9.7 (CI 7.5-12.7)] and ventricular tachycardia [HR: 7.7 (CI 4.2-14.3)] also occurred more often than in the control group. The risk of sudden cardiac death was increased [HR: 8.3 (CI 3.8-18.0)] but the etiology was unclear due to lack of autopsies.

conclusionNon-aortic cardiovascular disease in patients with MFS is exceptionally prevalent and the range of diseases varies between women and men. Physicians caring for MFS patients must be aware of this large spectrum of cardiovascular diseases.

Indexed as

Population SurveillanceRegistriesAdultCardiovascular DiseasesCause of DeathDenmarkEchocardiographyFemaleFollow-Up StudiesHumansIncidenceMaleMarfan SyndromeRetrospective StudiesSurvival RateYoung AdultCardiomyopathyEpidemiologyGenetic disordersHeart failureValve disease

Identifiers

PMID33885997
OpenAlexW3154767515

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.